Therapeutic targeting of SETD2-deficient cancer cells with the small-molecule compound RITA
K. A. Lopez, S. Sarkar, E. Seraia, C. Toffanin, C. Cooper, M. Challoumas, F. A. Okonjo, G. D. D. Jones, F. Buffa, D. Ebner, T. C. Humphrey
This paper identifies RITA as a compound that selectively kills SETD2-deficient cancer cells by inducing p53-mediated apoptosis and replication stress.
bioRxiv · Jul 8, 2021 · PreprintCell Biology